- Home
- INDB vs MLTX Comparison
INDB vs MLTX Comparison
Compare INDB & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDB
- MLTX
- Stock Information
- Founded
- INDB 1907
- MLTX 2021
- Country
- INDB United States
- MLTX Switzerland
- Employees
- INDB N/A
- MLTX N/A
- Industry
- INDB Major Banks
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- INDB Finance
- MLTX Health Care
- Exchange
- INDB Nasdaq
- MLTX Nasdaq
- Market Cap
- INDB 3.2B
- MLTX 2.8B
- IPO Year
- INDB N/A
- MLTX N/A
- Fundamental
- Price
- INDB $65.98
- MLTX $49.00
- Analyst Decision
- INDB Buy
- MLTX Strong Buy
- Analyst Count
- INDB 4
- MLTX 7
- Target Price
- INDB $69.50
- MLTX $73.33
- AVG Volume (30 Days)
- INDB 473.5K
- MLTX 463.2K
- Earning Date
- INDB 07-17-2025
- MLTX 08-06-2025
- Dividend Yield
- INDB 3.58%
- MLTX N/A
- EPS Growth
- INDB N/A
- MLTX N/A
- EPS
- INDB 4.44
- MLTX N/A
- Revenue
- INDB $654,155,000.00
- MLTX N/A
- Revenue This Year
- INDB $27.60
- MLTX $103.42
- Revenue Next Year
- INDB $25.32
- MLTX N/A
- P/E Ratio
- INDB $14.85
- MLTX N/A
- Revenue Growth
- INDB N/A
- MLTX N/A
- 52 Week Low
- INDB $49.85
- MLTX $31.42
- 52 Week High
- INDB $77.23
- MLTX $58.26
- Technical
- Relative Strength Index (RSI)
- INDB 56.92
- MLTX 63.01
- Support Level
- INDB $65.88
- MLTX $46.37
- Resistance Level
- INDB $67.75
- MLTX $49.29
- Average True Range (ATR)
- INDB 2.34
- MLTX 1.85
- MACD
- INDB 0.27
- MLTX 0.05
- Stochastic Oscillator
- INDB 82.29
- MLTX 88.30
About INDB Independent Bank Corp.
Independent Bank Corp is a bank holding company and the sole shareholder of its bank, the Rockland Trust Company. Rockland is a community-oriented commercial bank. The bank provides a variety of banking, investment and financial services, operating with various retail branches, as well as a network of commercial and residential lending centers and investment management offices majorly in Eastern Massachusetts, Worcester County, and Rhode Island. The bank's loan portfolio constitutes the bulk of the bank's total assets. Its borrowers consist mostly of small to medium-size businesses and consumers, majority of which are made to its market area in eastern Massachusetts and Rhode Island. The bank's loan portfolio is predominantly in commercial loans.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.